the enhanced chemiluminescence (ECL) procedure was employed for development
Am Heart J 139: S120-123 Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, et al
Peroxisomes metabolize a variety of fatty acids, acting as a chain-shortening -oxidation system that produces large amounts of acetyl-CoA

Ingredients: Galactomyces Ferment Filtrate, Glycerin, Cetyl Ethylhexanoate, Propanediol, Dicaprylyl Carbonate, 1,2-Hexanediol, Betaine, Cetearyl Alcohol, Polyglyceryl-10 Laurate, Methyl Trimethicone, Silica, Cetearyl Olivate, Panthenol, Phenyl Trimethicone, Potassium Cetyl Phosphate, Water, Sorbitan Olivate, Bisabolol, Ammonium Polyacryloyldimethyl Taurate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dipropylene Glycol, Squalane, Laminaria Japonica Extract, Eclipta Prostrata Leaf Extract, 3-O-Ethyl Ascorbic Acid, Glutathione, Ethylhexylglycerin, Fragrance, Lavandula Angustifolia (Lavender) Oil, Coptis Japonica Root Extract, Xanthan Gum, Butylene Glycol, Adenosine, Fructooligosaccharides, Sorbitan Isostearate, T-Butyl Alcohol, Hydrogenated Lecithin, Beta-Glucan, Hydrolyzed Hyaluronic Acid, Ascorbic Acid, Tocopherol, Allantoin, Ceramide NP, Oryza Sativa (Rice) Bran Oil, Oryza Sativa (Rice) Bran Extract, Glyceryl Stearate, Phytosphingosine, Cholesterol, Ceramide AP, Ceramide AS, Ceramide NS, Caprylyl Glycol, Ceramide NG, Ceramide EOP, Linalool, Limonene

International Journal of Dermatology, aot 2021, pages 1013-1018 2
KLOW Concentration Reference Table Storage After KLOW Reconstitution Lyophilized powder: 24 months at -20C, protected from light Reconstituted solution: 14 days at 2 to 8C under sterile conditions